New STAT1 Mutations in Healthy Patients with Mycobacterial Disease
Author Information
Author(s): Chapgier Ariane, Boisson-Dupuis Stéphanie, Jouanguy Emmanuelle, Vogt Guillaume, Feinberg Jacqueline, Prochnicka-Chalufour Ada, Casrouge Armanda, Yang Kun, Soudais Claire, Fieschi Claire, Santos Orchidée Filipe, Bustamante Jacinta, Picard Capucine, de Beaucoudrey Ludovic, Emile Jean-François, Arkwright Peter D, Schreiber Robert D, Rolinck-Werninghaus Claudia, Rösen-Wolff Angela, Magdorf Klaus, Roesler Joachim, Casanova Jean-Laurent
Primary Institution: Laboratory of Human Genetics of Infectious Diseases, University of Paris René Descartes, INSERM U550, Necker Medical School, Paris, France
Hypothesis
The study investigates the role of novel STAT1 alleles in patients with mycobacterial disease.
Conclusion
The study identifies two new STAT1 mutations that impair DNA-binding activity, contributing to susceptibility to mycobacterial disease.
Supporting Evidence
- The study characterizes three human STAT1 germline alleles.
- Patients with these alleles show impaired immunity to mycobacteria.
- The identified mutations affect different molecular mechanisms.
Takeaway
Some people can get sick from weak germs because of changes in their genes, but they can still fight off other viruses just fine.
Methodology
The study sequenced the coding regions of five genes associated with mycobacterial disease in patients and analyzed the effects of identified mutations.
Limitations
The study's findings may not apply to all patients with mycobacterial disease due to the low penetrance of the identified mutations.
Participant Demographics
The study involved two unrelated children with mild forms of Mendelian susceptibility to mycobacterial disease.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website